ArticleNPJ digital medicine2026
A device-invariant multi-modal learning framework for respiratory disease classification.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Recent advances in cough sound analysis using deep learning techniques enable smartphone-based respiratory disease screening suitable for self-management care in a home setting, yet their utility is limited by device heterogeneity, population diversity, and challenges in multimodal integration. We propose a device-invariant, multimodal deep learning framework that jointly models cough acoustics, demographic data, and symptom descriptions for multi-label classification of adult respiratory diseases. To address the issues of device effect, an adversarial branch is embedded in the audio encoder to enforce device-invariant feature learning, while an invariant risk minimization-augmented loss enhances robustness to non-structural shifts. To evaluate the effectiveness of our proposed method, a real-world, multi-center dataset containing over 10,000 cases spanning seven major respiratory conditions was curated. On the tasks of individual respiratory disease identification for chronic obstructive pulmonary disease (COPD), lower respiratory tract infection (LRTI) and pulmonary shadows (PS), our method achieves superior performance with the area under the receiver operating characteristic curve (AUROC) of 0.9698, 0.8483 and 0.8720, respectively. It also shows promising results in identifying the presence of comorbidities for 7 respiratory diseases with an overall AUROC of 0.8907. More importantly, extensive experimental results demonstrate our method mitigates the issues of device effect and facilitates the cross-device generalization for cough-based respiratory disease diagnoses. This work demonstrates a scalable and transferable AI-based approach for cough-driven respiratory screening, emphasizing the importance of multimodal fusion and robust representation learning in advancing clinical applicability.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.